83 related articles for article (PubMed ID: 4299982)
1. [Apropos of a hepatoma: rôle of regional chemotherapy].
Bessot M; Thevenin F; Fays J; Grilliat JP
Sem Hop; 1968 Jun; 44(29):1995-6. PubMed ID: 4299982
[No Abstract] [Full Text] [Related]
2. Continuous prolonged intrahepatic infusion of 5-fluorouracil in the treatment of hepatoma in Ibadan.
Francis TI
West Afr Med J Niger Pract; 1972 Feb; 21(1):18-20. PubMed ID: 4338412
[No Abstract] [Full Text] [Related]
3. [Treatment of cancer of the liver by regional perfusion].
Bessot M; Duprez A
J Chir (Paris); 1968 Feb; 95(2):185-202. PubMed ID: 4302978
[No Abstract] [Full Text] [Related]
4. Hepatoma: long-term survival with disseminated tumor treated with 5-fluorouracil.
Ramirez G; Ansfield FJ; Curreri AR
Am J Surg; 1970 Sep; 120(3):400-3. PubMed ID: 4318569
[No Abstract] [Full Text] [Related]
5. Dihydropyrimidine dehydrogenase activity in hepatocellular carcinoma: implication in 5-fluorouracil-based chemotherapy.
Jiang W; Lu Z; He Y; Diasio RB
Clin Cancer Res; 1997 Mar; 3(3):395-9. PubMed ID: 9815697
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma responding to chemotherapy with 5-FU.
Yoshida H; Onda M; Tajiri T; Umehara M; Mamada Y; Taniai N; Kaneko M; Mizuguchi Y; Uchida E; Yamashita K; Uchida E
Hepatogastroenterology; 2000; 47(34):1120-1. PubMed ID: 11020893
[TBL] [Abstract][Full Text] [Related]
7. [Selective chemotherapy of hepatocellular carcinomas].
Keppler D; Pausch J; Gerok W
Verh Dtsch Ges Inn Med; 1978; (84):606-10. PubMed ID: 217196
[No Abstract] [Full Text] [Related]
8. [Some data from a biochemical study of patients with primary cancer of the liver during chemotherapy].
Pashintseva LP; Krusanova NI; Assekritova IV
Vestn Akad Med Nauk SSSR; 1970; 25(2):39-43. PubMed ID: 4317645
[No Abstract] [Full Text] [Related]
9. Mitoxantrone, 5-FU + folinic acid, mitomycin C for regional chemotherapy of malignant liver tumors.
Link KH; Pillasch J; Weindel M; Leder G; Beger HG
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1380. PubMed ID: 8854758
[No Abstract] [Full Text] [Related]
10. Combination chemotherapy with 5-fluorouracil (NSC-19893), methotrexate (NSC-740), and prednisolone (NSC-9900) (FAP protocol) for hepatoma.
Umsawasdi T; Chainuvati T; Hitannant S; Nilprabhassorn P; Viranuvatti V
Cancer Chemother Rep; 1975; 59(6):1167-9. PubMed ID: 177190
[No Abstract] [Full Text] [Related]
11. Prolonged survival with hepatocellular carcinoma.
Penalba C; Larouze B; Mechali D; Saimot G; Coulaud JP
Gastroenterology; 1982 Nov; 83(5):1159. PubMed ID: 6288508
[No Abstract] [Full Text] [Related]
12. Cutaneous porphyria due to a malignant primary hepatoma.
Thompson RP; Nicholson DC; Farnan T; Whitmore DN; Williams R
Gastroenterology; 1970 Nov; 59(5):779-83. PubMed ID: 4319877
[No Abstract] [Full Text] [Related]
13. The efficacy of the combination therapy of 5-fluorouracil, cisplatin and leucovorin for hepatocellular carcinoma and its predictable factors.
Kogure T; Ueno Y; Iwasaki T; Shimosegawa T
Cancer Chemother Pharmacol; 2004 Apr; 53(4):296-304. PubMed ID: 14689231
[TBL] [Abstract][Full Text] [Related]
14. [Study in man of recirculation and tissue uptake of 5-FU 6 H3].
Bessot M; Duprez A; Mauuary G; Winsback AM
Biol Gastroenterol (Paris); 1971; 1():71-7. PubMed ID: 4327245
[No Abstract] [Full Text] [Related]
15. [Autopsy case of liver cancer undetected until the terminal stage].
Hattori M; Katsuta K; Hozumi M
Iryo; 1970 Mar; 24(3):249-55. PubMed ID: 4316183
[No Abstract] [Full Text] [Related]
16. [Primary cancer of the liver in a child detected by angiography and treated by exeresis and antimitotics].
Champeau M; Arsac M; Pineau P
Sem Hop; 1968 Jun; 44(29):1991-2. PubMed ID: 4299980
[No Abstract] [Full Text] [Related]
17. [Comments on the treatment of solid tumors with 5-fluorouracil].
Alberto P
Ther Umsch; 1969 Jul; 26(7):415-21. PubMed ID: 4308282
[No Abstract] [Full Text] [Related]
18. [A case of combined hepatocellular and cholangiocarcinoma showing tumor growth and invasion to the diaphragm during interferon-alpha and 5-fluorouracil combined intra-arterial chemotherapy].
Noda T; Nagano H; Marubashi S; Kobayashi S; Takeda Y; Murakami M; Tomimaru Y; Dono K; Umeshita K; Nakayama M; Shima T; Wakasa K; Monden M; Doki Y; Mori M
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2099-102. PubMed ID: 19106536
[TBL] [Abstract][Full Text] [Related]
19. Complete pathological response of hepatocellular carcinoma with systemic combination chemotherapy.
Ferrari D; Di Maria G; Fazio N; Codecà C; Fiore J; Luciani A; Oldani S; Maggioni M; Foa P
Anticancer Drugs; 2008 Sep; 19(8):837-40. PubMed ID: 18690097
[TBL] [Abstract][Full Text] [Related]
20. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Wada H; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Dono K; Monden M
J Hepatol; 2007 Jan; 46(1):77-88. PubMed ID: 17045692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
